Arzoxifene Hydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameArzoxifene Hydrochloride
Drug Alias Name阿佐昔芬ArzoxifenumArzoxifenoLY-353381SERM-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors modulators
TargetsEstrogen receptors
Therapy Area/IndicationsOsteoporosis, PostmenopausalOsteoporosisEndometrial Neoplasms +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[12
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsOsteoporosis, PostmenopausalOsteoporosisEndometrial Neoplasms +[7

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG